Thyrocare Technologies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Thyrocare Technologies Ltd. on BSE

Load latest

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Earnings Call

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording of post results earning conference call

pdf

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Thyrocare Technologies Results Earnings Call for Q4FY24

Conference Call with Thyrocare Technologies Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Company Update

Thyrocare Technologies Ltd - 539871 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) regulation, 2015

pdf

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Company Update

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

The Board of directors of the Company at their meeting held on May 14, 2024, approved the appointment of Mr. Anandh Sundar and Mr. Nishant Shah as additional director designated as Independent Director wef June 15, 2024

pdf

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are enclosing herewith a copy of the Investor presentation to be made to the investors at the earning conference call for Analysts and Investors to be held on May 14, 2024 on the audited financial results of the Company for the quarter and year ended March 31, 2024.

pdf

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Corp. Note

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Dividend Updates

BSE India

The Board has recommended a final dividend for Rs.18/- per share for the financial year 2023-24 for approval at ensuing Annual General Meeting

pdf

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Result

Thyrocare Technologies Ltd - 539871 - Financials Results For The Quarter And Year Ended 31 March …

BSE India

Please find attached herewith Audited financial results for the Quarter and year ended 31 March 2024.

pdf

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Board Meeting

Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

we wish to inform you that the Board has at its meeting held today i.e. May 14, 2024, inter alia, considered and approved the audited financial results (standalone and consolidated) for the quarter and financial year ended on March 31, 2024. Pursuant to Regulation 33(3) of SEBI Listing Regulations, the standalone and consolidated audited financial results for the quarter and financial year ended on March 31, 2024, along with the Audit Reports on said financial results issued by the Statutory Auditors of the Company, are attached as Annexure - A. The Board has recommended a final Dividend of Rs. 18/- per equity share of face value of Rs. 10/- each for the financial year 2023-24, for approval at the ensuing Annual General Meeting.

pdf

Thyrocare Technologies Ltd.

14 May 2024

1002.30

-0.75%

Annual Report

Annual report for Thyrocare Technologies Ltd. for FY-2024

None

pdf

Thyrocare Technologies Ltd.

07 May 2024

1002.30

-0.75%

Company Update

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

The conference call for the analysts/investors has been arranged by the management of the company to discuss the Company's financial results for the quarter and financial year ended March 31, 2024

pdf

Is Thyrocare Technologies Ltd. worth buying?

165 Votes:

Buy 76.97%

Sell 12.12%

Hold 10.91%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf